Fetzima (Levomilnacipran) Side Effects: List of Possibilities
Fetzima (Levomilnacipran) is a serotonin-norepinephrine reuptake inhibitor that was approved by the FDA in 2013 to treat major depression. It is similar to the older drug milnacipran, but contains the “levo”-stereoisomer – making it slightly different. This antidepressant is regarded as being significantly different from other SNRIsĀ in that it inhibits norepinephrine reuptake to a greater …